EP2710032

Umbreytt glýkóprótín

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    18.5.2012
  • EP published:
    25.12.2019
  • EP application number:
    12790362.3
  • Max expiry date:
    17.5.2032
  • Title:
    MODIFIED GLYCOPROTEINS

Timeline

Today
18.5.2012EP application
25.12.2019EP Publication
22.1.2020Translation submitted
15.2.2020Registration published

Owner

  • Name:
    Momenta Pharmaceuticals, Inc.
  • Address:
    301 Binney Street, Cambridge, MA 02142, US

Inventor

  • Name:
    BULIK, Dorota, A.
  • Address:
    Malden, MA 02148, US
  • Name:
    BOSQUES, Carlos, J.
  • Address:
    Arlington, MA 02476, US
  • Name:
    COLLINS, Brian, Edward
  • Address:
    Arlington, MA 02474, US
  • Name:
    HAINS, Maurice, Gaston
  • Address:
    Brockton, MA 02301, US
  • Name:
    WASHBURN, Nathaniel, J.
  • Address:
    Littleton, MA 01460, US
  • Name:
    MEADOR, James
  • Address:
    Framingham, MA 01702, US
  • Name:
    SMITH, Sean
  • Address:
    Littleton, MA 01460, US
  • Name:
    BHATNAGAR, Naveen
  • Address:
    Framingham, MA 01702, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201161488523 P
  • Date:
    20.5.2011
  • Country:
    US
  • Number:
    201261638134 P
  • Date:
    25.4.2012
  • Country:
    US

Classification

  • Categories:
    C07K 16/00, C12P 21/08

Upload documents